Chroma Medicine

Chroma Medicine was a Boston-based, clinical-stage biotechnology company developing epigenetic editors — CRISPR-derived medicines that silence or activate genes by writing epigenetic marks rather than cutting DNA — with CRMA-1001, a liver-targeted epigenetic editing therapy for chronic hepatitis B and hepatitis D, as its lead program. In December 2024 it merged with Nvelop Therapeutics, pairing Chroma's epigenetic editors with Nvelop's non-viral in vivo delivery vehicles, to form nChroma Bio with $75 million in new financing. chromamedicine.com now redirects to nchromabio.com. As a therapeutics developer it publishes no developer program, public API, SDK, or machine-readable specification of any kind.

Chroma Medicine is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Genetic Medicine, and Epigenetic Editing.

🌐 Visit website 📡 Source on GitHub
6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyLife SciencesGenetic MedicineEpigenetic EditingTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 6.8/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.8 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/chroma-medicine: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 1

The organization behind the API

Website
Website

Other 1

Properties that don't map to a standard resource type

SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: chroma-medicine
name: Chroma Medicine
description: Chroma Medicine was a Boston-based, clinical-stage biotechnology company developing epigenetic editors — CRISPR-derived
  medicines that silence or activate genes by writing epigenetic marks rather than cutting DNA — with CRMA-1001, a liver-targeted
  epigenetic editing therapy for chronic hepatitis B and hepatitis D, as its lead program. In December 2024 it merged with
  Nvelop Therapeutics, pairing Chroma's epigenetic editors with Nvelop's non-viral in vivo delivery vehicles, to form nChroma
  Bio with $75 million in new financing. chromamedicine.com now redirects to nchromabio.com. As a therapeutics developer it
  publishes no developer program, public API, SDK, or machine-readable specification of any kind.
url: https://raw.githubusercontent.com/api-evangelist/chroma-medicine/refs/heads/main/apis.yml
image: https://www.nchromabio.com/wp-content/uploads/2026/03/cropped-nChroma-Isolated-Logo-270x270.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-09'
modified: '2026-08-09'
tags:
- Company
- Biotechnology
- Life Sciences
- Genetic Medicine
- Epigenetic Editing
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.nchromabio.com/
- type: PrivacyPolicy
  url: https://www.nchromabio.com/privacy-policy/
- type: SecondaryMarket
  url: https://forgeglobal.com/chroma-medicine_stock/
x-enrichment:
  date: '2026-08-09'
  status: minimal
  pass: local-v1
  artifacts_added: 0
x-coverage:
  state: none
  reason: defunct
  detail: Chroma Medicine no longer exists as a standalone company — it merged with Nvelop Therapeutics in December 2024 to
    form nChroma Bio, and chromamedicine.com now 301s to www.nchromabio.com, a six-page WordPress marketing site for a clinical-stage
    genetic medicines developer with no developer, API, or documentation section.
  evidence:
  - url: https://chromamedicine.com
    status: 301
  - url: https://www.nchromabio.com/
    status: 200
  - url: https://www.nchromabio.com/openapi.json
    status: 404
  - url: https://www.nchromabio.com/.well-known/agent-card.json
    status: 404
  - url: https://www.nchromabio.com/developers
    status: 404
  - url: https://api.github.com/orgs/chromamedicine
    status: 404
  checked: '2026-08-09'